Advertisement
U.S. markets open in 2 hours 36 minutes

AmeriCann, Inc. (ACAN)

Other OTC - Other OTC Delayed Price. Currency in USD
0.06000.0000 (0.00%)
At close: 10:53AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0600
Open0.0625
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0600 - 0.0675
52 Week Range0.0510 - 0.4150
Volume2,070
Avg. Volume19,400
Market Cap1.464M
Beta (5Y Monthly)1.42
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateMay 15, 2024 - May 19, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ACAN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • AMERICANN INC
    Analyst Report: Exact Sciences CorporationExact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.
    Rating
    Fair Value
    Economic Moat
    yesterdayMorningstar
View more
  • ACCESSWIRE

    AmeriCann Releases Record Annual Financial Results

    (via IBN)AmeriCann Inc. (OTCQB:ACAN) (the "Company"), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, has released financial and operational results for its quarter ending March 2023.